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CLINICAL
REHABILITATION
Clinical and cost effectiveness of 
memory rehabilitation following 
traumatic brain injury: a pragmatic 
cluster randomized controlled trial
Roshan das Nair1,2 , Lucy E Bradshaw3,  
Florence EC Day3, Avril Drummond4, Shaun RS Harris5,  
Deborah Fitzsimmons5, Alan A Montgomery3, Gavin Newby6, 
Catherine Sackley7 and Nadina B Lincoln8
Abstract
Objective: To evaluate the clinical and cost effectiveness of a group-based memory rehabilitation 
programme for people with traumatic brain injury.
Design: Multicentre, pragmatic, observer-blinded, randomized controlled trial in England.
Setting: Community.
Participants: People with memory problems following traumatic brain injury, aged 18–69 years, able to 
travel to group sessions, communicate in English, and give consent.
Interventions: A total of 10 weekly group sessions of manualized memory rehabilitation plus usual care 
(intervention) vs. usual care alone (control).
Main measures: The primary outcome was the patient-reported Everyday Memory Questionnaire 
(EMQ-p) at six months post randomization. Secondary outcomes were assessed at 6 and 12 months post 
randomization.
Results: We randomized 328 participants. There were no clinically important differences in the primary 
outcome between arms at six-month follow-up (mean EMQ-p score: 38.8 (SD 26.1) in intervention and 
44.1 (SD 24.6) in control arms, adjusted difference in means: –2.1, 95% confidence interval (CI): –6.7 to 2.5, 
p = 0.37) or 12-month follow-up. Objectively assessed memory ability favoured the memory rehabilitation 
arm at the 6-month, but not at the 12-month outcome. There were no between-arm differences in 
mood, experience of brain injury, or relative/friend assessment of patient’s everyday memory outcomes, 
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but goal attainment scores favoured the memory rehabilitation arm at both outcome time points. Health 
economic analyses suggested that the intervention was unlikely to be cost effective. No safety concerns 
were raised.
Conclusion: This memory rehabilitation programme did not lead to reduced forgetting in daily life for a 
heterogeneous sample of people with traumatic brain injury. Further research will need to examine who 
benefits most from such interventions.
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Introduction
Approximately 65% of people with moderate–
severe traumatic brain injury report long-term 
problems with cognitive functioning, with memory 
being most disrupted.1 Cognitive dysfunctions are 
persistent and debilitating, reduce quality of life, 
and are the leading cause of disability in traumatic 
brain injury.2
Memory rehabilitation aims to retrain memory 
and help people compensate for deficits. Patients 
are taught the use of external and internal memory 
aids, sometimes with computer-assisted delivery, 
and typically delivered as individual or group inter-
ventions in community settings. However, with 
shrinking healthcare budgets, group formats are 
increasingly being commissioned in the United 
Kingdom,3 assuming that these are cost and resource 
efficient, and clinically beneficial, but research evi-
dence to support such decisions is weak.
National clinical guidelines4,5 for adult trau-
matic brain injury rehabilitation recommend teach-
ing patients ‘compensatory memory strategies’ to 
improve everyday functioning.4 However, meta-
analyses have suggested that the evidence of effec-
tiveness of such interventions is sparse,6,7 with 
several small, methodologically weak studies 
contributing much of the evidence. In fact, a key 
recommendation from the Lancet Neurology 
Commission was that ‘Robust evidence is needed 
to inform guidelines on medical, surgical, and 
rehabilitation interventions, and hence improve 
outcomes for patients with TBI [traumatic brain 
injury]’.8
Our aim was to determine the clinical and cost 
effectiveness of a group-based memory rehabilita-
tion programme for community-dwelling people 
with memory problems following traumatic brain 
injury.
Methods
This was a multicentre, two-arm, parallel group, 
pragmatic randomized controlled trial of group-
based memory rehabilitation plus usual care, 
compared with usual care alone. Ethical approval 
was obtained from the National Research Ethics 
Service (12/EM/0324) and the Ministry of 
Defence Research Ethics Committee (374/
PPE/12). The study was prospectively registered 
(ISRCTN65792154) and the protocol was pub-
lished.9 This project was funded by the National 
Institute for Health Research (NIHR), Health 
Technology Assessment Programme (project no. 
10/57/24) between September 2012 and May 
2017. The funder had no role in study design, data 
collection, analysis, interpretation, or writing of 
the report.
Participants and procedures
Participants were recruited from nine English 
National Health Service (NHS) Trusts providing 
rehabilitation services for people with traumatic 
brain injury, and from a military rehabilitation cen-
tre and an NHS surgical centre treating armed 
forces personnel. Participants also self-referred 
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following publicity by brain injury charities and 
patient groups, and by advertising to the general 
public.
The participants satisfying the following criteria 
were eligible:
•• Were admitted to hospital with a traumatic 
brain injury more than three months prior to 
recruitment;
•• Had memory problems, defined as a score ⩾24 
on the Everyday Memory Questionnaire – 
patient version10 or a score <25th percentile on 
the Rivermead Behavioural Memory Test – 
version 3;11
•• Were 18–69 years of age;
•• Were able to travel to one of the study sites 
and attend group sessions, and willing to 
receive treatment in a group if allocated to 
intervention;
•• Gave written consent.
We excluded those with the following:
•• Unable to engage in group treatment if allo-
cated, such as severe hearing or behavioural 
problems, which was assessed by the clinicians 
at recruitment sites;
•• Participating in other psychological interven-
tion studies;
•• With impairment of language, scoring <17 on 
the Sheffield Screening Test for Acquired 
Language Disorders.12
After a screening visit to confirm eligibility and 
a second visit to collect baseline data and set short- 
and long-term goals, clusters of 4–6 eligible par-
ticipants who could attend a group at the same time 
and place were formed. Participants were randomly 
allocated, as a cluster, to intervention or usual care 
on a 1:1 ratio. The allocation sequence was strati-
fied by study site and based on a computer- generated 
pseudo-random code using random permuted 
blocks of randomly varying size. Allocation was 
concealed using a secure web-based system devel-
oped and maintained by the Nottingham Clinical 
Trials Unit. Blinding of participants and Assistant 
Psychologists delivering the intervention was not 
possible. Researchers collecting secondary out-
come data at 6- and 12-month follow-up visits 
were blinded to treatment allocation.
All participants received their usual clinical 
care, which was recorded in the resource use ques-
tionnaire. The intervention was memory rehabilita-
tion, as described in our published protocol,9 and 
delivered following an intervention manual. Details 
of the intervention following the Template for 
Intervention Description and Replication (TIDieR) 
guidelines13 are provided in Supplemental Table 1.
Outcome assessments were completed 6 and 
12 months post randomization using self-report 
questionnaires and face-to-face assessments. 
Outcome measures reflected the three levels of the 
International Classification of Function:14 impair-
ment, activity limitations, and participation restric-
tions, and were selected on the basis of their clinical 
utility, relevant psychometric properties, and 
patient feedback. The primary follow-up was 
6 months after randomization, with a 12-month 
assessment to determine longer term effects.
The primary outcome measure was the 28-item 
patient-reported version of the Everyday Memory 
Questionnaire – patient version10 that assesses the 
frequency of memory failures in everyday life over 
the past month. Each item was rated on a five-point 
Likert-type scale (‘once or less in the last month/
never’ to ‘once or more a day’). We chose a patient-
reported outcome because (1) of its ecological 
validity, (2) our Patient and Public Involvement 
group felt this was essential, (3) Cochrane Reviews 
of cognitive rehabilitation have concluded that 
‘future research should use outcomes that are 
deemed important by service users’,15 and (4) sub-
jective cognitive outcomes have been used in sev-
eral memory rehabilitation trials.16
The secondary outcomes were an objective 
evaluation of everyday memory (Rivermead 
Behavioural Memory Test General Memory 
Index),11 patient-reported outcomes of mood 
(General Health Questionnaire – 30-item ver-
sion),17 experience of brain injury (European Brain 
Injury Questionnaire – patient version modified 
version),18 and personal short- and long-term goal 
attainment. Participants also nominated a relative/
friend who completed the relative version of the 
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Everyday Memory Questionnaire and the European 
Brain Injury Questionnaire – relative version.
The cost effectiveness of memory rehabilitation 
was evaluated from the UK NHS and Personal 
Social Services perspective. The primary health 
economic outcomes were a bespoke resource use 
questionnaire and EuroQol19 Quality of Life – five-
dimensional questionnaire, five-level version 
(EQ-5D-5L).
Intervention sessions were video recorded and a 
trained independent observer rated these on minute 
intervals and compared what was covered in the 
sessions with what was in the manual. Therapist 
skill at delivering the intervention was also assessed 
independently and reported elsewhere.20,21
Analyses
To detect a minimum clinically relevant difference 
in the mean of 12 points on the Everyday Memory 
Questionnaire – patient version, with 5% two-
sided alpha, 90% power, and SD 21.9, requires 71 
participants per arm for analysis in an individually 
randomized trial. Assuming that 10% of variance 
in outcome would be explained by centre as a 
fixed effect (based on four centres), allowing for 
clustering due to the group intervention (cluster 
size of 6 and intracluster correlation coefficient of 
0.1), and accounting for 20% attrition, the target 
sample size was 312 (calculated using the ‘Optimal 
Design’ software).22 
The main approach to analysis was modified 
intention-to-treat, that is, analysis according to rand-
omized arm regardless of adherence to allocation and 
including participants who provided outcome data, 
within three months of the due date, at follow-up.
We estimated the difference in mean outcome 
scores between the two arms using a multilevel lin-
ear model with site and baseline score as the covar-
iates. Although participants were randomly 
allocated in clusters, individuals in the usual care 
arm had no contact with each other and outcomes 
in this arm were therefore assumed to be independ-
ent. However, participants in the intervention arm 
received memory rehabilitation sessions in groups. 
We therefore used a fully heteroscedastic model23 
recommended for analysis of trials comparing 
group-based treatments with individual-based 
treatment, when there is adjustment for individual-
level covariates. This model estimated group-level 
residual variance in the intervention arm and also 
permitted individual-level residual variance to dif-
fer between the intervention and control arms.23 
Assumptions for the multilevel linear model were 
checked using diagnostic plots.
Sensitivity analyses for the primary outcome 
used multiple imputation for missing outcome data 
and explored the impact of attendance at group ses-
sions by estimating the complier average causal 
effect24 at six months using instrumental variable 
regression. Adherence which was defined as 
attending at least four memory rehabilitation ses-
sions. Details of the sensitivity analysis are pub-
lished elsewhere.20
A planned exploratory subgroup analysis on the 
primary outcome was performed according to 
memory impairment at baseline using the 
Rivermead Behavioural Memory Test General 
Memory Index split into three clinically meaning-
ful groups, based on the test manual25 (significant 
impairment, borderline/moderate, and average/
above-average range), by including an interaction 
term in the model. Following the planned analyses, 
trial collaborators suggested that the time since 
traumatic brain injury could potentially affect 
intervention effectiveness. We therefore conducted 
a post hoc subgroup analysis for time since trau-
matic brain injury.
The EQ-5D-5L scores were used to derive utili-
ties to calculate quality adjusted life year (QALY) 
scores using the England valuation set.26 Multiple 
imputation was used to address missing data and 
baseline differences were controlled for by a multi-
level linear model. The multiple-imputation-
adjusted costs and outcomes were used for the base 
case analysis. As the time horizon was 12 months, 
discounting of costs and effects was not done.
A cost utility analysis was undertaken. An 
incremental cost effectiveness ratio was used to 
summarize the incremental cost per additional 
QALY gained as a result of memory rehabilitation, 
based on the multiple-imputation-adjusted analy-
sis for the base case. One-way sensitivity analyses 
were undertaken to evaluate whether changes to 
das Nair et al. 1175
costs or effects (based on the lower and upper 
bound confidence interval (CI) values) influenced 
the incremental cost effectiveness ratio when other 
values remained at the base case level. To assess 
the impact of joint uncertainty, non-parametric 
bootstrapping was used across 1000 replications 
with a cost effectiveness acceptability curve pro-
duced to ascertain the probability of memory reha-
bilitation being cost effective across different 
willingness-to-pay thresholds, with £20,000–
£30,000 per QALY gained used to indicate whether 
memory rehabilitation would be considered cost 
effective.
All analyses were conducted using Stata/SE 
13.1. Details were documented in the statistical 
analysis plan, which was finalized prior to database 
lock and release of treatment allocation codes. 
Trial Steering and Data Monitoring Committees 
provided independent oversight of the trial.
Results
We invited 4023 people with traumatic brain 
injury to participate between February 2013 and 
December 2015. Non-eligibility and recruitment 
being closed at the site were the main reasons par-
ticipants were not randomized after consent. We 
exceeded the randomization target because par-
ticipants were randomized in clusters. Figure 1 
outlines the number and flow of participants 
throughout the trial.
Follow-up was completed between October 
2013 and December 2016. Questionnaire return 
and visit completion were similar in the two arms 
at both time points. The primary analysis included 
129 (75%) participants in the memory rehabilita-
tion arm and 122 (78%) in the usual care arm. The 
main reason participants were not included was 
due to not completing questionnaires. We com-
pared the baseline characteristics of participants 
according to completion of the primary outcome 
and the allocated group. In both groups, partici-
pants with no primary outcome data tended to have 
a slightly lower level of educational attainment and 
slightly more memory problems at baseline based 
on both patient and relative/friend report than par-
ticipants with primary outcome data.
Participant characteristics were well balanced 
between arms at baseline (Table 1).
Participants in the intervention arm attended a 
mean of 6.3 memory rehabilitation sessions (SD 
3.5); 131 participants (77%) attended four or more 
sessions. The number of days from the last treat-
ment session to six-month visit and questionnaire 
were as follows: median: 92 (interquartile range 
(IQR): 76–105) and median: 80 (IQR: 59–98), 
respectively.
There was no clinically important difference 
on the Everyday Memory Questionnaire – 
patient version at 6 months between the two 
arms (Table 2) or at 12 months (Table 3). 
Memory ability on the Rivermead Behavioural 
Memory Test favoured the memory rehabilita-
tion arm at 6 months; however, there was no evi-
dence of a difference at 12 months. There was 
no evidence of any difference on the General 
Health Questionnaire–30 at 6 or 12 months. 
Goal attainment scores favoured the memory 
rehabilitation arm at both 6 and 12 months.
Scores from all subscales of the European Brain 
Injury Questionnaire – patient version were similar 
in the two arms at 6 and 12 months (Supplemental 
Table 2). The differences between the two arms at 
follow-up based on the relative/friend assessments 
on the Everyday Memory Questionnaire – relative 
version and European Brain Injury Questionnaire 
– relative version were consistent with the partici-
pant-completed questionnaires (Table 4 and Supple-
mental Table 3).
Sensitivity analyses for the primary outcome 
found similar results to the primary analysis.20 
There was no evidence of difference in the effect of 
the memory rehabilitation sessions across sub-
groups based on baseline memory impairment 
(Rivermead Behavioural Memory Test General 
Memory Index); the p-value for interaction effect 
was 0.12. However, the difference in mean 
Everyday Memory Questionnaire – patient version 
score in the subgroup of those with borderline/
moderate memory impairment favoured the mem-
ory rehabilitation arm (adjusted difference in 
means: –7.1 (95% CI: –13.9 to −0.3, n = 102). 
There was no evidence of a difference in the inter-
vention effect according to the time since traumatic 
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brain injury (interaction effect p = 0.48; see 
Supplemental Table 4).
Usual care, based on information from the 
resource use questionnaire and feedback interview 
data (published elsewhere),20 suggested that partici-
pants largely received no memory rehabilitation, 
and for the few that received this, it was brief and 
was terminated shortly after being discharged from 
hospital.
The cost of the memory rehabilitation pro-
gramme was estimated at £167 per participant in the 
memory rehabilitation arm. Memory rehabilitation 
Figure 1. Flow diagram.
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Table 1. Baseline characteristics.
Usual care (n = 157) Memory rehabilitation 
(n = 171)
Age (years)
 Mean [SD] 45.1 [12.5] 45.8 [11.5]
Gender
 Men 116 (74%) 123 (72%)
 Women 41 (26%) 48 (28%)
Ethnicity
 White 147 (94%) 167 (98%)
 Black 6 (3%) 2 (1%)
 Mixed race 3 (2%) 1 (1%)
 Other 1 (1%) 1 (1%)
Residential status
 Living alone 44 (28%) 43 (25%)
 Living with others 106 (68%) 120 (70%)
 Living with informal care 2 (1%) 1 (1%)
 Living with formal care 2 (1%) 0
 Living in care home 3 (2%) 7 (4%)
Highest educational attainment
 Below GCSE 26 (17%) 29 (17%)
 GCSE 54 (34%) 49 (29%)
 A-Level 42 (27%) 34 (20%)
 Degree 24 (15%) 41 (24%)
 Higher degree 10 (6%) 17 (10%)
 Not known 1 (1%) 1 (1%)
Employment status at screening (not mutually exclusive)
 Not employed 80 (51%) 85 (50%)
 Employed full-time 25 (16%) 38 (22%)
 In education full-time 2 (1%) 1 (1%)
 Voluntary full-time 1 (1%) –
 Retired 17 (11%) 15 (9%)
 Employed part-time 25 (16%) 19 (11%)
 Voluntary part-time 9 (6%) 17 (10%)
Time since TBI (months)
 Median [25th centile, 75th centile] 46 [23, 116] 58 [24, 148]
EMQ-p (participant-reported frequency of memory problems in everyday life)
 Mean [SD] 50.1 [24.6] 47.4 [21.0]
RBMT-3 General Memory Index (assessed memory abilities)  
 Mean [SD] 76.3 [14.5] 77.7 [13.6]
GCSE: General Certificate of Secondary Education; EMQ-p: Everyday Memory Questionnaire (patient version); TBI: traumatic 
brain injury; RBMT-3: Rivermead Behavioural Memory Test; GMI: General Memory Index.
EMQ-p scores range from 0 to 112 with higher scores indicating more frequent/important memory problems. RBMT-3 GMI 
scores range between 52 and 174 and have been standardized to have a mean of 100 and an SD of 15 on a demographically repre-
sentative sample from the United Kingdom.
was £27 (95% CI: –455.13 to 401.34) less expensive 
compared to usual care; however, this was not 
statistically significant (p = 0.91; Table 5). Memory 
rehabilitation generated less QALYs, with 0.011 
(95% CI: −0.031 to 0.01) fewer QALYs generated 
compared to usual care, but this was not statistically 
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Table 2. Primary and secondary outcomes at six-month follow-up.
Baseline, mean [SD] Six-month follow-up,  
mean [SD]
Adjusted difference in  
means (95% CI)
EMQ-p (primary outcome)
 Usual care (n = 122) 48.9 [23.9] 44.1 [24.6]
–2.1 (–6.7 to 2.5),  
p = 0.37
 Memory rehabilitation (n = 129) 45.9 [21.0] 38.8 [26.1]
General Health Questionnaire 30
 Usual care (n = 110) 33.9 [15.7] 34.1 [16.8]
–1.6 (–5.3 to 2.1) Memory rehabilitation (n = 124) 36.2 [15.4] 33.6 [16.3]
RBMT-3 GMI
 Usual care (n = 133) 77.1 [14.5] 79.1 [15.0]
2.5 (0.1 to 4.8) Memory rehabilitation (n = 141) 78.9 [13.7] 82.7 [14.0]
Short-term goal attainment average score
 Usual care (n = 131) – 1.2 [1.0]
0.6 (0.3 to 0.9) Memory rehabilitation (n = 141) – 1.8 [1.0]
Long-term goal attainment average score
 Usual care (n = 131) – 1.0 [0.9]
 Memory rehabilitation (n = 141) – 1.5 [1.0] 0.5 (0.2 to 0.7)
CI: confidence interval; EMQ-p: Everyday Memory Questionnaire (patient version); RBMT-3: Rivermead Behavioural Memory 
Test; GMI: General Memory Index.
Table 3. Secondary outcomes at 12-month follow-up.
Baseline, mean [SD] 12-month follow-up,  
mean [SD]
Adjusted difference in  
means (95% CI)
EMQ-p
 Usual care (n = 107) 47.5 [24.6] 43.0 [26.7]
–4.8 (–9.6 to 0.0) Memory rehabilitation (n = 124) 46.7 [20.4] 38.0 [25.0]
General Health Questionnaire 30
 Usual care (n = 103) 33.4 [15.8] 32.5 [18.8]
−0.2 (–4.5 to 4.1) Memory rehabilitation (n = 119) 35.7 [15.3] 33.1 [18.5]
RBMT-3 GMI
 Usual care (n = 124) 76.2 [14.0] 84.0 [18.4]
0.5 (–2.6 to 3.6) Memory rehabilitation (n = 131) 79.5 [12.8] 87.2 [15.7]
Short term goal attainment average score
 Usual care (n = 123) – 1.5 [1.1]
0.3 (0.0 to 0.5) Memory rehabilitation (n = 131) – 1.8 [0.9]
Long term goal attainment average score
 Usual care (n = 123) – 1.3 [1.0]
 Memory rehabilitation (n = 131) – 1.6 [1.0] 0.4 (0.1 to 0.6)
CI: confidence interval; EMQ-p: Everyday Memory Questionnaire (patient version); RBMT-3: Rivermead Behavioural Memory 
Test; GMI: General Memory Index.
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significant (p = 0.44). This produced a base case 
incremental cost effectiveness ratio of £2445 reflect-
ing that memory rehabilitation was less costly but 
was less effective compared to usual care.
The sensitivity analyses (Supplemental Table 5) 
demonstrated considerable uncertainty, with results 
changing based on the imputation method used or 
when the costs and outcomes were varied by lower 
and upper CI ranges. Evaluation of joint uncer-
tainty in the cost effectiveness plane (Figure 2) 
revealed point estimates located across all four 
quadrants. The probability of memory rehabilita-
tion being cost effective at 12 months at a willing-
ness-to-pay threshold of £20,000 per QALY gain 
was estimated at 29% and 24% at £30,000 per 
QALY.
No safety concerns were raised and no deaths 
reported.
Discussion
Our results suggest that there was no benefit of 
this group-based memory rehabilitation pro-
gramme for this heterogeneous sample with trau-
matic brain injury as a whole, with no clinically 
important difference on the Everyday Memory 
Questionnaire – patient version between the two 
arms at six-month follow-up. We also found con-
sistent results from most of the secondary out-
comes. Goal attainment scores, however, indicated 
that the individual goals were marginally better 
met in the memory rehabilitation (intervention) 
arm compared to the usual care (control) arm at 
both 6- and 12-month follow-ups.
In the following section, we consider why our 
results are different from much of the extant litera-
ture, which has considered memory rehabilitation 
Table 4. Everyday Memory Questionnaire – relative version (EMQ-r).
Baseline, mean [SD] Follow-up, mean [SD] Adjusted difference in means 
(95% CI)
EMQ-r – frequency of problems
6-month follow-up
 Usual care (n = 66) 43.2 [23.1] 40.9 [25.9]
–4.2 (–10.1 to 1.7) Memory rehabilitation (n = 68) 39.4 [26.3] 31.8 [24.5]
12-month follow-up
 Usual care (n = 57) 42.9 [23.5] 37.6 [26.6]
 Memory rehabilitation (n = 67) 40.0 [26.7] 32.2 [26.2] –5.3 (–12.0 to 1.4)
CI: confidence interval.
Table 5. Cost and quality adjusted life year (QALY) outcomes at 12-month follow-up.
Usual care 
(n = 157), mean 
(95% CI)
Memory 
rehabilitation 
(n = 171), mean 
(95% CI)
Incremental 
(bootstrapped  
95% CI)
ICER (£)
Costs 1423.62 (1031.97, 
1815.27)
1396.72 (1091.91, 
1701.54)
−26.89 (–455.13, 
401.34)
2445 CE plane: 
southwest 
quadrant
QALYs 0.004 (−0.017, 
0.025)
−0.007 (−0.025, 
0.012)
−0.011 (−0.031, 
0.011)
Intervention less 
costly and less 
effective than usual 
care
CI: confidence interval; ICER: incremental cost effectiveness ratio; CE: cost effectiveness.
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as largely effective. Indeed, the National Institute 
for Health and Care Excellence’s (NICE)27 quality 
statement for community rehabilitation services for 
adults with traumatic brain injury recommends that 
patients are offered rehabilitation (‘neuropsycho-
logical therapy’) after leaving hospital to help them 
recover their independence and return to their daily 
lives, and reviews of effectiveness of cognitive 
rehabilitation in traumatic brain injury28 have con-
cluded that interventions for memory impairments 
are beneficial.
A meta-analysis6 of Cicerone et al.’s7,28 reviews 
identified two crucial issues. First, there were test–
retest effects, with a pre–post effect size of 0.21 
(standard error = 0.15) in the control group in five 
studies of memory interventions. This suggests that 
people in this group were also improving. Second, 
non-controlled studies appeared to be skewing the 
evidence of effectiveness, with an effect size of 
0.61 (95% CI: 0.37 to 0.85) in 14 single-group 
pre–post studies of memory training. Based on five 
studies focusing on memory interventions with a 
control group, this meta-analysis6 did not find a 
beneficial effect of memory training on memory 
measures (effect size: 0.18; 95% CI: −0.16 to 0.53).
Another review of the effectiveness of memory 
rehabilitation in stroke and traumatic brain injury29 
found that dissemination bias was present. This 
suggests that findings from studies with ‘negative’ 
or ‘neutral’ results may not have been published. 
The review authors, therefore, suggest that the 
overall effect of memory rehabilitation may be 
overestimated. Furthermore, this review also found 
‘spontaneous’ changes not attributable to the mem-
ory rehabilitation. Traumatic brain injury–specific 
data were unavailable, but the authors found a 
moderate (r = 0.31) and significant (Z = 10.00, 
p < 0.05) improvement in memory in the control 
group not attributable to the intervention. They 
also found a significant (Z = 20.62, p < 0.05) and 
Figure 2. Cost effectiveness plane for bootstrapped quality adjusted life years (QALYs) at 12 months.
This figure represents the cost effectiveness plane with health outcomes (effects) plotted on the x-axis and costs on the y-axis. 
The data (represented as individual dots) are derived from 1000 bootstrapped resampling estimations and are plotted on four 
quadrants. In this graph, the largest proportion of point estimates is located in the bottom-left quadrant consistent with the inter-
vention being less costly and less effective than usual care.
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moderate effect (r = 0.51) of the interventions that 
could not be attributed to the passage of time or 
spontaneous recovery. Our data also demonstrate 
some improvements in memory scores for the con-
trol group. This degree of change over time, which 
for traumatic brain injury can occur over a life-
time,30 warrants further investigation.
Another issue is that some memory rehabilita-
tion interventions that have been evaluated have 
specifically targeted the constituent components 
of the wider construct of memory (such as work-
ing memory training), which may improve with 
targeted practice. Therefore, improvements may 
be seen only when the outcome assessments are 
similar to the intervention. However, the degree to 
which such specific interventions are likely to 
generalize to patients’ daily life is yet to be 
established.
The lack of ‘positive’ findings could also be 
attributed to the intervention we delivered (in rela-
tion to the content, ‘dose’, therapist skill, etc.), the 
participants we included, or the outcomes we 
chose.
The content of our intervention is similar to 
other published memory rehabilitation studies7,28 
and resonates with clinical practice. There is, how-
ever, no consensus about what is the appropriate 
number of intervention sessions for memory reha-
bilitation. In one meta-analysis,6 the mean treat-
ment duration was 13.3 weeks (SD = 14.2), and 
ours was 10 sessions over 10 weeks. We assumed, 
based on our previous studies,31,32 and given the 
modular structure of the programme, that people 
would find some benefit from attending at least 
four sessions. This is also consistent with our clini-
cal practice. Given that our sample had memory 
problems, attendance at the memory rehabilitation 
groups was good, with 77% attending four or more 
sessions. However, it could be argued that attend-
ing only four sessions is not enough to effect 
changes, but research is still needed to determine 
the dose–effect relationship.
Most memory rehabilitation trials have been 
small (n ≈ 36).6 The ReMemBrIn trial exceeded 
the target sample size of 312 randomized partici-
pants and provided an estimate of the primary 
treatment effect that was sufficiently precise to 
exclude the predefined minimum clinical relevant 
effect size. The primary analysis included data 
from 75%–78% of the sample due to non-comple-
tion of questionnaires. This level of completion is 
not uncommon for participants with traumatic 
brain injury and memory problems.33
One limitation of this study is that we were una-
ble to describe the nature and severity of partici-
pants’ traumatic brain injury because of our wide 
recruitment strategy that included people attending 
brain injury charity day care centres. We, therefore, 
did not have access to their medical notes. However, 
we are unaware of any research that has found dif-
ferential treatment effects of cognitive rehabilita-
tion based on location or degree of traumatic brain 
injury, and given the randomization, this variable is 
likely to be balanced between both intervention 
and control groups.
The heterogeneity of our sample in terms of 
demographic characteristics, traumatic brain 
injury characteristics, and severity of memory 
problems is both a strength and a limitation. The 
sample was representative of traumatic brain 
injury patients seen in many UK community reha-
bilitation settings. However, the group may have 
included some who would not typically have 
received ongoing rehabilitation due to lack of 
improvement in early rehabilitation. The mean 
Everyday Memory Questionnaire – patient version 
scores were consistent with other traumatic brain 
injury populations,34 but impaired relative to 
healthy controls.35 However, some with severe 
memory problems may not have been able to 
retain enough information from groups to apply it 
in their daily lives. We also included some people 
who were not actively seeking help for their prob-
lems and were participating for altruistic reasons 
rather than to help themselves. This may have 
diluted treatment effects.
We recruited clusters of participants based on 
who could attend the same day and venue. In clini-
cal practice, however, there are sometimes attempts 
to group members with similar characteristics 
together. Our procedure may have led to groups 
with very mixed memory abilities, attitudes, and 
lifestyles, which may have made it harder to 
achieve group cohesion and for participants to 
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learn from each other. However, it would not have 
been possible to match participants on all such var-
iables when composing a group within the remit of 
a time-limited trial. Therapists were taught to deal 
with this heterogeneity when attempting to indi-
vidually tailor the intervention, particularly for 
homework, and were able to adjust the intervention 
delivery based on group composition. Our previous 
qualitative research showed that participants did 
not mind the heterogeneity,32 and the high attend-
ance rates in this study may also reflect this. 
Furthermore, we are unaware of research that has 
described the ideal composition of memory groups 
to effect best outcomes, and this is largely based on 
clinical judgement.
Another strength was that all the trial therapists 
were trained to deliver the intervention with com-
petence and confidence, and there was little varia-
bility in terms of their competence.20 Regular 
supervision and monitoring (including video 
recording of sessions) enabled fidelity to the treat-
ment delivery.
The primary outcome was self-reported by par-
ticipants who were aware of their treatment alloca-
tion. We recognize that these subjective accounts 
could have been influenced by the respondent’s 
mood,36 and mood improvements have been noted 
following memory rehabilitation in smaller tri-
als.37–39 However, this was not observed in our 
study.
It could be argued that because our primary out-
come was at six months post randomization, if 
there were improvements immediately after the 
intervention, this may have diminished by the time 
of the assessment. The median number of days 
between the end of the treatment sessions and the 
primary outcome assessment was however only 
80 days (IQR: 59–98 days). We were mindful of the 
impact of repeated testing, potential practice 
effects, and participant burden, so did not consider 
having more than two outcome time points.
Future research could explore the role of mod-
erator variables in relation to outcomes, and 
breaking down the constituent parts of everyday 
memory (based on the factor structure of the 
Everyday Memory Questionnaire) to determine 
which aspects are most responsive to memory 
rehabilitation. We determined the minimum clini-
cally relevant difference in mean Everyday 
Memory Questionnaire – patient version based on 
our pilot data and patient interviews; however, 
further research is required to determine whether 
this difference should be varied based on time 
since injury (with the expectation that longer term 
survivors would show less change than those 
more recently diagnosed). More work needs to be 
done to determine who benefits most from mem-
ory rehabilitation. Finally, as a complex interven-
tion, outcomes of memory rehabilitation are likely 
to be determined by not only the content of the 
intervention, but also by how the intervention is 
delivered. Therefore, future studies could con-
sider therapist variables and the impact of thera-
peutic alliance in relation to outcomes.
Clinical message
•• Community-based group memory reha-
bilitation for a heterogeneous group of 
long-term survivors of traumatic brain 
injury does not reduce forgetting in daily 
life and is unlikely to be cost effective.
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